Health ❯ Public Health ❯ Disease Prevention

Vaccination Strategies

Community Health Flu Vaccines FDA Recommendations Elderly Health Infectious Disease Vaccines Triple Viral Vaccine Clinical Trials Surveillance Measures Immune System Response Global Health Initiatives Booster Shots Insect-borne Disease Prevention Health Communication Global TB Burden Access to Vaccines HSV Prophylaxis Pre-pandemic Vaccination Risk Assessment Oral Presentations Post-Exposure Treatment Dengue Vaccination Infant Immunization At-Risk Populations Health Campaigns Measles Vaccine Epstein-Barr Virus Vaccine Community Engagement Immunology Immunization Challenges Travel Health Advisory Genetic Considerations Economic Impact Flu Season Mucosal Vaccination School-Based Vaccination Programs Pandemic Preparedness Health Care Providers

FDA Advisers Recommend XFG as Target for 2026–2027 COVID-19 Vaccines

The recommendation steers fall vaccine production toward XFG to boost protection against the currently dominant JN.1-family strains.

Rectal Mucosal Vaccine Clears C. Diff in Animals, Nature Study Finds

Dengue Infection Rewires Innate Immunity, Boosting Vaccine Response in Previously Exposed People

Colorado Warns of Measles Exposure at DIA Concourse C as Second Mesa County Case Signals Possible Local Spread

Genetic Ancestry Shapes Dengue Severity Through Skin Inflammatory Response